• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向更具现实意义的可生物降解微粒体外释放测量技术

Towards more realistic in vitro release measurement techniques for biodegradable microparticles.

作者信息

Klose D, Azaroual N, Siepmann F, Vermeersch G, Siepmann J

机构信息

College of Pharmacy, JE 2491, University of Lille, 3 rue du Professeur Laguesse, 59006, Lille, France.

出版信息

Pharm Res. 2009 Mar;26(3):691-9. doi: 10.1007/s11095-008-9747-4. Epub 2008 Oct 29.

DOI:10.1007/s11095-008-9747-4
PMID:18958404
Abstract

PURPOSE

To better understand the importance of the environmental conditions for drug release from biodegradable microparticles allowing for the development of more appropriate in vitro release measurement techniques.

METHODS

Propranolol HCl diffusion in various agarose gels was characterized by NMR and UV analysis. Fick's law was used to theoretically predict the mass transport kinetics. Drug release from PLGA-based microparticles in such agarose gels was compared to that measured in agitated bulk fluids ("standard" method).

RESULTS

NMR analysis revealed that the drug diffusivity was almost independent of the hydrogel concentration, despite of the significant differences in the systems' mechanical properties. This is due to the small size of the drug molecules/ions with respect to the hydrogel mesh size. Interestingly, the theoretically predicted drug concentration-distance-profiles could be confirmed by independent experiments. Most important from a practical point of view, significant differences in the release rates from the same batch of PLGA-based microparticles into a well agitated bulk fluid versus a semi-solid agarose gel were observed.

CONCLUSION

Great care must be taken when defining the in vitro conditions for drug release measurements from biodegradable microparticles. The obtained new insight can help facilitating the development of more appropriate in vitro release testing procedures.

摘要

目的

为了更好地理解环境条件对可生物降解微粒药物释放的重要性,从而开发更合适的体外释放测量技术。

方法

通过核磁共振(NMR)和紫外(UV)分析对盐酸普萘洛尔在各种琼脂糖凝胶中的扩散进行表征。利用菲克定律从理论上预测传质动力学。将基于聚乳酸-羟基乙酸共聚物(PLGA)的微粒在这种琼脂糖凝胶中的药物释放与在搅拌的大量流体中测量的结果(“标准”方法)进行比较。

结果

核磁共振分析表明,尽管体系的机械性能存在显著差异,但药物扩散系数几乎与水凝胶浓度无关。这是由于相对于水凝胶网孔尺寸,药物分子/离子尺寸较小。有趣的是,理论预测的药物浓度-距离曲线可以通过独立实验得到证实。从实际角度来看,最重要的是,观察到同一批基于PLGA的微粒在充分搅拌的大量流体与半固体琼脂糖凝胶中的释放速率存在显著差异。

结论

在确定可生物降解微粒药物释放的体外条件时必须格外小心。所获得的新见解有助于推动开发更合适的体外释放测试程序。

相似文献

1
Towards more realistic in vitro release measurement techniques for biodegradable microparticles.迈向更具现实意义的可生物降解微粒体外释放测量技术
Pharm Res. 2009 Mar;26(3):691-9. doi: 10.1007/s11095-008-9747-4. Epub 2008 Oct 29.
2
Drug release from PLGA-based microparticles: effects of the "microparticle:bulk fluid" ratio.PLGA 基微球的药物释放:“微球:体相流体”比例的影响。
Int J Pharm. 2010 Jan 4;383(1-2):123-31. doi: 10.1016/j.ijpharm.2009.09.012. Epub 2009 Sep 11.
3
PLGA-based drug delivery systems: importance of the type of drug and device geometry.基于聚乳酸-羟基乙酸共聚物的药物递送系统:药物类型和装置几何形状的重要性。
Int J Pharm. 2008 Apr 16;354(1-2):95-103. doi: 10.1016/j.ijpharm.2007.10.030. Epub 2007 Oct 30.
4
Theoretical prediction of induction period from transient pore evolvement in polyester-based microparticles.聚酯基微球中瞬态孔演变诱导期的理论预测。
J Pharm Sci. 2010 Nov;99(11):4477-87. doi: 10.1002/jps.22167.
5
Pore size distributions of biodegradable polymer microparticles in aqueous environments measured by NMR cryoporometry.通过核磁共振低温孔隙率测定法测量的水性环境中可生物降解聚合物微粒的孔径分布。
Int J Pharm. 2006 Feb 17;309(1-2):157-62. doi: 10.1016/j.ijpharm.2005.11.027. Epub 2005 Dec 28.
6
Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.完美的溶蚀条件对微球中 PLGA 降解的非预期潜在影响。
Int J Pharm. 2011 Feb 14;404(1-2):75-82. doi: 10.1016/j.ijpharm.2010.10.054. Epub 2010 Nov 5.
7
A study of drug release from homogeneous PLGA microstructures.聚丙交酯乙交酯共聚物(PLGA)微结构中药物释放的研究。
J Control Release. 2010 Sep 1;146(2):201-6. doi: 10.1016/j.jconrel.2010.03.024. Epub 2010 Apr 8.
8
Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.使用超临界二氧化碳技术制备、表征负载吲哚美辛的聚乳酸/聚乳酸-羟基乙酸共聚物微粒及其体外细胞毒性
Eur J Pharm Biopharm. 2008 Sep;70(1):85-97. doi: 10.1016/j.ejpb.2008.03.011. Epub 2008 Mar 29.
9
Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory.释放介质类型对基于聚乳酸-羟基乙酸共聚物(PLGA)的微粒药物释放的影响:实验与理论
Int J Pharm. 2006 May 18;314(2):189-97. doi: 10.1016/j.ijpharm.2005.07.030. Epub 2006 Feb 28.
10
Altering the drug release profiles of double-layered ternary-phase microparticles.改变双层三元相微球的药物释放曲线。
J Control Release. 2011 May 10;151(3):229-38. doi: 10.1016/j.jconrel.2011.02.012. Epub 2011 Feb 23.

引用本文的文献

1
A dataset on formulation parameters and characteristics of drug-loaded PLGA microparticles.一个关于载药聚乳酸-羟基乙酸共聚物(PLGA)微粒的制剂参数和特性的数据集。
Sci Data. 2025 Mar 1;12(1):364. doi: 10.1038/s41597-025-04621-9.
2
In vitro-in vivo correlation (IVIVC) development for long-acting injectable drug products based on poly(lactide-co-glycolide).基于聚(丙交酯-乙交酯)的长效注射用药物产品的体外-体内相关性(IVIVC)研究
J Control Release. 2025 Jan 10;377:186-196. doi: 10.1016/j.jconrel.2024.11.021. Epub 2024 Nov 19.
3
Drug release from PLGA microparticles can be slowed down by a surrounding hydrogel.

本文引用的文献

1
Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.向大脑进行局部控释给药:潜在物质传输机制的数学建模
Int J Pharm. 2006 May 18;314(2):101-19. doi: 10.1016/j.ijpharm.2005.07.027. Epub 2006 May 2.
2
How porosity and size affect the drug release mechanisms from PLGA-based microparticles.孔隙率和粒径如何影响基于聚乳酸-羟基乙酸共聚物(PLGA)的微粒的药物释放机制。
Int J Pharm. 2006 May 18;314(2):198-206. doi: 10.1016/j.ijpharm.2005.07.031. Epub 2006 Feb 28.
3
Methods to assess in vitro drug release from injectable polymeric particulate systems.
周围的水凝胶可以减缓药物从聚乳酸-羟基乙酸共聚物(PLGA)微粒中的释放。
Int J Pharm X. 2023 Nov 28;6:100220. doi: 10.1016/j.ijpx.2023.100220. eCollection 2023 Dec 15.
4
How bulk fluid renewal can affect in vitro drug release from PLGA implants: Importance of the experimental set-up.大量液体更新如何影响PLGA植入物的体外药物释放:实验设置的重要性。
Int J Pharm X. 2022 Sep 19;4:100131. doi: 10.1016/j.ijpx.2022.100131. eCollection 2022 Dec.
5
Antibacterial coaxial hydro-membranes accelerate diabetic wound healing by tuning surface immunomodulatory functions.抗菌同轴水凝胶膜通过调节表面免疫调节功能加速糖尿病伤口愈合。
Mater Today Bio. 2022 Aug 13;16:100395. doi: 10.1016/j.mtbio.2022.100395. eCollection 2022 Dec.
6
Methodological Considerations in Development of UV Imaging for Characterization of Intra-Tumoral Injectables Using cAMP as a Model Substance.开发用于使用 cAMP 作为模型物质表征肿瘤内注射剂的 UV 成像的方法学考虑因素。
Int J Mol Sci. 2022 Mar 25;23(7):3599. doi: 10.3390/ijms23073599.
7
Muscle Tissue as a Surrogate for In Vitro Drug Release Testing of Parenteral Depot Microspheres.肌肉组织作为注射用储库型微球体外药物释放试验的替代物。
AAPS PharmSciTech. 2021 Mar 29;22(3):119. doi: 10.1208/s12249-021-01965-4.
评估可注射聚合物微粒系统体外药物释放的方法。
Pharm Res. 2006 Mar;23(3):460-74. doi: 10.1007/s11095-005-9397-8. Epub 2006 Jan 13.
4
Development of a dialysis in vitro release method for biodegradable microspheres.用于可生物降解微球的透析体外释放方法的开发。
AAPS PharmSciTech. 2005 Oct 6;6(2):E323-8. doi: 10.1208/pt060242.
5
How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment.自催化如何加速基于聚乳酸-羟基乙酸共聚物(PLGA)的微粒的药物释放:定量研究。
Biomacromolecules. 2005 Jul-Aug;6(4):2312-9. doi: 10.1021/bm050228k.
6
Mapping neutral microclimate pH in PLGA microspheres.绘制聚乳酸-羟基乙酸共聚物(PLGA)微球中的中性微气候pH值
J Control Release. 2005 Jan 3;101(1-3):163-73. doi: 10.1016/j.jconrel.2004.07.029.
7
Polymer microspheres for controlled drug release.用于控释药物的聚合物微球。
Int J Pharm. 2004 Sep 10;282(1-2):1-18. doi: 10.1016/j.ijpharm.2004.04.013.
8
A realistic brain tissue phantom for intraparenchymal infusion studies.用于脑实质内输注研究的逼真脑组织模型。
J Neurosurg. 2004 Aug;101(2):314-22. doi: 10.3171/jns.2004.101.2.0314.
9
Assuring quality and performance of sustained and controlled released parenterals.确保缓释和控释肠胃外给药制剂的质量和性能。
Eur J Pharm Sci. 2004 Apr;21(5):679-90. doi: 10.1016/j.ejps.2004.03.001.
10
In vitro degradation of three-dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering.用于组织工程的三维多孔聚(D,L-丙交酯-共-乙交酯)支架的体外降解
Biomaterials. 2004 Dec;25(27):5821-30. doi: 10.1016/j.biomaterials.2004.01.038.